Literature DB >> 12550741

Functional interactions between cannabinoid and metabotropic glutamate receptors in the central nervous system.

James Doherty1, Raymond Dingledine.   

Abstract

The recent appreciation that two G-protein-coupled receptors, metabotropic glutamate and cannabinoid, are trans-synaptically linked by a small lipid messenger has profound implications, both for control of synaptic transmission and for novel therapeutic strategies. There is much evidence for this assertion and on the significance of this dual receptor cooperation for modulation of synaptic transmission in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12550741     DOI: 10.1016/s1471-4892(02)00014-0

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  15 in total

Review 1.  Emerging roles for endocannabinoids in long-term synaptic plasticity.

Authors:  Gregory L Gerdeman; David M Lovinger
Journal:  Br J Pharmacol       Date:  2003-09-22       Impact factor: 8.739

Review 2.  Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function?

Authors:  A Galvan; M Kuwajima; Y Smith
Journal:  Neuroscience       Date:  2006-10-23       Impact factor: 3.590

3.  Role of Paraventricular Nucleus Glutamate Signaling in Regulation of HPA Axis Stress Responses.

Authors:  Nathan K Evanson; James P Herman
Journal:  Interdiscip Inf Sci       Date:  2015-09-13

Review 4.  The function of metabotropic glutamate receptors in thalamus and cortex.

Authors:  S Murray Sherman
Journal:  Neuroscientist       Date:  2013-03-04       Impact factor: 7.519

5.  Roles of mGluR5 in synaptic function and plasticity of the mouse thalamocortical pathway.

Authors:  Wei-Chi She; Charles Quairiaux; Michael J Albright; Yu-Chi Wang; Denisse E Sanchez; Poh-Shing Chang; Egbert Welker; Hui-Chen Lu
Journal:  Eur J Neurosci       Date:  2009-03-23       Impact factor: 3.386

Review 6.  Supraspinal modulation of pain by cannabinoids: the role of GABA and glutamate.

Authors:  K Rea; M Roche; D P Finn
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

7.  Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.

Authors:  Erin A McClure; Susan C Sonne; Theresa Winhusen; Kathleen M Carroll; Udi E Ghitza; Aimee L McRae-Clark; Abigail G Matthews; Gaurav Sharma; Paul Van Veldhuisen; Ryan G Vandrey; Frances R Levin; Roger D Weiss; Robert Lindblad; Colleen Allen; Larissa J Mooney; Louise Haynes; Gregory S Brigham; Steve Sparenborg; Albert L Hasson; Kevin M Gray
Journal:  Contemp Clin Trials       Date:  2014-08-30       Impact factor: 2.226

8.  Retroinhibition of presynaptic Ca2+ currents by endocannabinoids released via postsynaptic mGluR activation at a calyx synapse.

Authors:  Christopher Kushmerick; Gareth D Price; Holger Taschenberger; Nagore Puente; Robert Renden; Jacques I Wadiche; Robert M Duvoisin; Pedro Grandes; Henrique von Gersdorff
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

Review 9.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

10.  Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.

Authors:  Deepak Cyril D'Souza; Daniel J Fridberg; Patrick D Skosnik; Ashley Williams; Brian Roach; Nagendra Singh; Michelle Carbuto; Jacqueline Elander; Ashley Schnakenberg; Brian Pittman; R Andrew Sewell; Mohini Ranganathan; Daniel Mathalon
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.